| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $44.3M | +58.8% |
| SG&A Expense | $15.7M | +43.4% |
| Operating Income | -$60.0M | -54.5% |
| Pre-tax Income | -$54.7M | -43.4% |
| Net Income | -$54.7M | -43.4% |
| EPS (Basic) | -$0.33 | -32.0% |
| EPS (Diluted) | -$0.33 | -32.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.6M | -49.0% |
| Short-term Investments | $135.7M | +84.0% |
| Current Assets | $165.9M | +28.7% |
| Total Assets | $177.6M | +27.0% |
| Current Liabilities | $10.6M | +80.6% |
| Long-term Debt | $26.3M | +1.0% |
| Total Liabilities | $37.2M | +16.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.1M | -47.8% |
| Capital Expenditures | $296K | +3188.9% |
| Investing Cash Flow | -$57.1M | -208.5% |
| Financing Cash Flow | $82.8M | — |
| Free Cash Flow | -$51.4M | -48.6% |
| Stockholders' Equity |
| $140.4M |
| +30.2% |